In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
New approaches to risk prediction
Session

Event : ESC Congress 2019

Topic : Research Methodology: Big Data Analysis

  • Session type : Moderated Posters
  • Date : 03 September 2019
  • Time : 14:40 - 15:30

7 presentations in this session

Machine learning for phenotyping and risk prediction in cardiovascular diseases: a systematic review

Event : ESC Congress 2019

  • Session : New approaches to risk prediction
  • Speaker : A Banerjee (London,GB)

Finding predictors and causes of cardiac surgery ICU readmission using machine learning and causal inference

Event : ESC Congress 2019

  • Session : New approaches to risk prediction
  • Speaker : J Lee (Baltimore,US)

An evaluation of the use of propensity scores in cardiovascular literature: a systematic review and recommendations

Event : ESC Congress 2019

  • Session : New approaches to risk prediction
  • Speaker : J Rouette (Montreal,CA)

Balancing risk and benefit in patients with atrial fibrillation: the GARFIELD-AF risk score

Event : ESC Congress 2019

  • Session : New approaches to risk prediction
  • Speaker : K Fox (Edinburgh,GB)

External validation of the ACEF II operative risk model in a cardiac surgery population: an interim evaluation

Event : ESC Congress 2019

  • Session : New approaches to risk prediction
  • Speaker : M Georgievska (Skopje,MK)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are